Hong‐Fei Yao

430 total citations
26 papers, 262 citations indexed

About

Hong‐Fei Yao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hong‐Fei Yao has authored 26 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Hong‐Fei Yao's work include Pancreatic and Hepatic Oncology Research (9 papers), RNA modifications and cancer (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Hong‐Fei Yao is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), RNA modifications and cancer (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Hong‐Fei Yao collaborates with scholars based in China and United Kingdom. Hong‐Fei Yao's co-authors include Yan‐Miao Huo, Yongwei Sun, Shu-Heng Jiang, Dejun Liu, Jian Yang, Minwei Yang, Chongyi Jiang, Xiaoyan Tang, Chunjing Li and Ling‐Ye Tao and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Frontiers in Immunology and Gene.

In The Last Decade

Hong‐Fei Yao

22 papers receiving 262 citations

Peers

Countries citing papers authored by Hong‐Fei Yao

Since Specialization

Citations

This map shows the geographic impact of Hong‐Fei Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong‐Fei Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong‐Fei Yao more than expected).

Fields of papers citing papers by Hong‐Fei Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong‐Fei Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong‐Fei Yao. The network helps show where Hong‐Fei Yao may publish in the future.

Co-authorship network of co-authors of Hong‐Fei Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Hong‐Fei Yao. A scholar is included among the top collaborators of Hong‐Fei Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong‐Fei Yao. Hong‐Fei Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A biomimetic dual-targeting nanomedicine for pancreatic cancer therapy 2025 ·Journal of Materials Chemistry B ·Guihua Zhou, Yuan Zhang, Zhiwei Cai, Hong‐Fei Yao, Meng Liu, Chongyi Jiang, Zhen Cheng	6
2	TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the β-catenin-c-MYC-GLUT1 axis 2025 ·International Journal of Biological Sciences ·Yifan Yin, Yixuan Sun, Hong‐Fei Yao, Yu Feng, (unknown), (unknown), Yanna Zhu, (unknown), Dejun Liu, Yongwei Sun, Yan‐Miao Huo, Minwei Yang, Wei Liu	0
3	ENO1 promotes PDAC progression by inhibiting CD8+ T cell infiltration through upregulating PD-L1 expression via HIF-1α signaling 2025 ·Translational Oncology ·(unknown), Shuyu Xiao, Yang Yan, (unknown), Xiaqing Li, (unknown), Hailong Ma, Hong‐Fei Yao, Linli Yao, Li-Peng Hu, Jun Li, Shu‐Heng Jiang, (unknown), (unknown), (unknown), Xueli Zhang	5
4	Vitamin D Binding Protein, a Ligand of Integrin beta 1, Motivates Both Tumor Cells and Schwann Cells to Promote Perineural Invasion in Pancreatic Ductal Adenocarcinoma 2025 ·Advanced Science ·Shan Zhang, (unknown), (unknown), Zhengyan Weng, Yanna Zhu, Zhiwei Cai, Hui Li, Qing Li, Lipeng Hu, Hong‐Fei Yao, (unknown), Yu Zhao, Dongxue Li, Xiaomei Yang, Junfeng Zhang, Shu‐Heng Jiang	0
5	SERINC2-mediated serine metabolism promotes cervical cancer progression and drives T cell exhaustion 2025 ·International Journal of Biological Sciences ·Yixuan Sun, Zhou Yang, (unknown), (unknown), (unknown), Ruiwen Wang, (unknown), Huixian Huang, Hong‐Fei Yao, He Li, Xueli Zhang, Lipeng Hu, Shu‐Heng Jiang, Zhigang Zhang, Dongxue Li, (unknown), Yincheng Teng	3
6	Schwann cells in pancreatic cancer: Unraveling their multifaceted roles in tumorigenesis and neural interactions 2024 ·Cancer Letters ·(unknown), Hong‐Fei Yao, Jiahao Chen, (unknown), Chunjing Li, Xiao Hu, Xiaoyan Tang, Chongyi Jiang	30
7	Evaluation of a new scoring system for assessing nerve invasion in resected pancreatic cancer: A single-center retrospective analysis 2024 ·Cancer Letters ·Rong Hua, Hong‐Fei Yao, (unknown), Yu Feng, (unknown), (unknown), (unknown), (unknown), (unknown), Minwei Yang, Jianyu Yang, Shan Zhang, (unknown)	5
8	Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarcinoma 2024 ·Cell Death and Disease ·(unknown), (unknown), Hong‐Fei Yao, (unknown), (unknown), (unknown), (unknown), Minwei Yang, Jianyu Yang, Junfeng Zhang, Dejun Liu, Rong Hua, Yan‐Miao Huo, Xueliang Fu, Yongwei Sun, Wei Liu	1
9	A potent nano-strategy for dual energy deprivation to inhibit pancreatic cancer progression 2024 ·Nano Today ·Yifan Yin, Zifan Pei, Chengyu Hu, Yixuan Sun, (unknown), Hong‐Fei Yao, (unknown), (unknown), (unknown), Dejun Liu, Yongwei Sun, Nan Jiang, Fei Gong, Nailin Yang, Liang Cheng, Wei Liu	7
10	Establishment of disulfidptosis-related LncRNA signature as biomarkers in colon adenocarcinoma 2024 ·Cancer Cell International ·Hong‐Fei Yao, Peng Liu, Linli Yao, Xiao Li	3
11	A CLIC1 network coordinates matrix stiffness and the Warburg effect to promote tumor growth in pancreatic cancer 2024 ·Cell Reports ·(unknown), (unknown), Jian Yang, (unknown), (unknown), (unknown), Hong‐Fei Yao, (unknown), (unknown), Li-Peng Hu, Qing Li, Shu-Heng Jiang, Yan‐Miao Huo, Wei Liu, Yongwei Sun, Dejun Liu	18
12	Unveiling an anoikis-related risk model and the role of RAD9A in colon cancer 2024 ·International Immunopharmacology ·(unknown), Yanli Liu, Hailong Guo, Xiaofei Peng, Bo Zhang, Dong Wang, Hong‐Fei Yao, Junfeng Zhang, Xiaoyun Wang, Pengcheng Chen, Dapeng Xu	2
13	Prediction of immune infiltration and prognosis for patients with cholangiocarcinoma based on a cuproptosis-related lncRNA signature 2023 ·Heliyon ·Hong‐Fei Yao, Min He, (unknown), Bo Zhang, Pengcheng Chen, Yan‐Miao Huo, Junfeng Zhang, (unknown)	3
14	Analysis of cuproptosis-related lncRNA signature for predicting prognosis and tumor immune microenvironment in pancreatic cancer 2023 ·APOPTOSIS ·Hong‐Fei Yao, Dapeng Xu, (unknown), Yu Xu, (unknown), (unknown), Jian Yang, Ruizhe He, Ding Ma, Minwei Yang, Xueliang Fu, (unknown), Yan‐Miao Huo, Jian‐Yu Yang, Junfeng Zhang	15
15	Increased SPON1 promotes pancreatic ductal adenocarcinoma progression by enhancing IL‐6 trans‐signalling 2022 ·Cell Proliferation ·Yan‐Miao Huo, Jian Yang, (unknown), Dapeng Xu, Minwei Yang, Ling‐Ye Tao, Hong‐Fei Yao, Xueliang Fu, Jian‐Yu Yang, Dejun Liu, Rong Hua, Junfeng Zhang, Yongwei Sun, Li-Peng Hu, Wei Liu	9
16	GJB3 promotes pancreatic cancer liver metastasis by enhancing the polarization and survival of neutrophil 2022 ·Frontiers in Immunology ·Yan‐Miao Huo, Yaoqi Zhou, (unknown), Guangxin Jin, Ling‐Ye Tao, Hong‐Fei Yao, Junfeng Zhang, Yongwei Sun, Yingbin Liu, Li-Peng Hu	23
17	Glycolysis addiction compensating for a defective pentose phosphate pathway confers gemcitabine sensitivity in SETD2-deficient pancreatic cancer 2022 ·Biochemical and Biophysical Research Communications ·Xuqing Shen, Yueyue Chen, Mingzhu Liu, Juanjuan Shi, (unknown), Xiaotong Yang, Dapeng Xu, Hong‐Fei Yao, Ping Lu, Yongwei Sun, Jing Xue, Ningning Niu	6
18	Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment 2022 ·Cellular Oncology ·(unknown), (unknown), (unknown), (unknown), Hong‐Fei Yao, Jian Yang, Yongwei Sun, Shu-Heng Jiang, Dejun Liu, Yan‐Miao Huo	63
19	ADAMTS12 promotes migration and epithelial-mesenchymal transition and predicts poor prognosis for pancreatic cancer 2022 ·Hepatobiliary & pancreatic diseases international ·Ruizhe He, (unknown), Hong‐Fei Yao, Dapeng Xu, Minwei Yang, Dejun Liu, Yongwei Sun, Yan‐Miao Huo	10
20	IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer 2022 ·Cellular Oncology ·Jian Yang, Dejun Liu, (unknown), Ruizhe He, Dapeng Xu, Minwei Yang, Hong‐Fei Yao, Xueliang Fu, Jian‐Yu Yang, Yan‐Miao Huo, Ling‐Ye Tao, Rong Hua, Yongwei Sun, Xianming Kong, Shu‐Heng Jiang, Wei Liu	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact